$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Mass spectrometry (MS)-based proteomics is an indispensable research tool in identifying disease specific biomarkers, understanding disease progression, and creating leads for therapeutic development. This can be achieved from a range of disease-related clinical samples such as blood serum/plasma, proximal fluids, and tissues1,2. Proteomics biomarker discovery and validation have recently gained significant consideration due to the power of sample multiplexing strategies3,4. Sample multiplexing is a technique that enables simultaneous comparison and quantification of two or more sample conditions within a single MS injection5,6. Sample multiplexing is achieved by barcoding peptides or proteins from multiple samples with chemical, enzymatic, or metabolic tags and obtaining MS information from all samples in a single MS or MS/MS experiment. Among the available isobaric tags are isobaric tagging reagents (iTRAQ), commercial tandem mass tags (TMT), and in house synthesized isobaric N,N-dimethyl leucine (DiLeu) reagents with capabilities up to 16-plex7 and 21-plex8, respectively.
Combined precursor isotopic labeling and isobaric tagging (cPILOT) is an enhanced sample multiplexing technology. cPILOT combines isotopic labeling of peptide N-termini with light [−(CH3)2] and heavy [−(13C2H3)2] isotopes at low pH (∼2.5), which keeps the lysine residue available for subsequent high pH (8.5) isobaric labeling using TMT, DiLeu, or iTRAQ tagging3,9,10,11,12,13,14. The dual labeling scheme of the cPILOT strategy is depicted in Supplemental Figure 1 with two samples using an example peptide. The accuracy and precision of the TMT based quantification at the MS2 level can be compromised due to the presence of contaminating co-isolated and co-fragmented ions termed as the interference effect15. This limitation in inaccurate reporter ion ratios can be overcome with the help of tribrid Orbitrap mass spectrometers. For example, the interference effect can be overcome by isolating a peak in a dimethylated pair at the MS1 level in the mass spectrometer, subjecting the light or heavy peak to MS2 fragmentation in the linear ion trap and then subjecting the most intense MS2 fragment for HCD-MS3 to obtain quantitative information. In order to increase the chances of selecting the peptides without lysine amines available for generating reporter ions, a selective MS3 acquisition based on the y-1 fragment also can be used and is an approach which can result in a higher percentage of peptides quantifiable with cPILOT9. The combination of light and heavy labeling increases sample multiplexing capabilities by a factor of 2x to that achieved with individual isobaric tags. We have recently used cPILOT to combine up to 24 samples in a single experiment with DiLeu reagents16. Additionally cPILOT has been used to study oxidative post-translational modifications14 including protein nitration17, other global proteomes9, and has demonstrated applications across multiple tissue samples in an Alzheimer’s disease mouse model11.
Robust sample preparation is a critical step in a cPILOT experiment and can be time-consuming, laborious, and extensive. Enhanced sample multiplexing requires extensive pipetting and highly skilled laboratory personnel, and there are several factors that can heavily influence the reproducibility of the experiment. For example, careful handling of samples is necessary to ensure similar reaction times for all samples and to maintain appropriate buffer pH for light and heavy dimethylated samples. Furthermore, manual preparation of tens to hundreds of samples can introduce high experimental error. Therefore, to reduce sample preparation variability, improve quantitative accuracy, and increase experimental throughput, we developed an automated cPILOT workflow. Automation is achieved using a robotic liquid handling device that can complete many aspects of the workflow (Figure 1). Sample preparation from protein quantification to peptide labeling was performed on an automated liquid handler. The automated liquid handler is integrated with a positive pressure apparatus (PPA) for buffer exchanges between the solid-phase extraction (SPE) plates, orbital shaker, and a heating/cooling device. The robotic platform contains 28 deck locations to accommodate plates and buffers. There are two pods with a gripper to transfer the plates within the deck locations: a 96-channel fixed volume pipetting head (5-1100 µL) and 8 channel variable volume probes (1-1000 µL). The robotic platform is controlled using a software. The user needs to be professionally trained prior to using the robotic liquid handler. The present study focuses on automating the manual cPILOT workflow, which can be labor intensive for processing more than 12 samples in a single batch. In order to increase the throughput of the cPILOT approach11, we transferred the cPILOT protocol to a robotic liquid handler to process more than 10 samples in parallel. The automation also allows similar reactions for each sample in parallel during various steps of the sample preparation process, which required highly trained users to achieve during manual cPILOT. This protocol focuses on the implementation of the automated liquid handling device to carry out cPILOT. The present study describes the protocol for using this automated system and demonstrates its performance using a 22-plex “proof-of-concept” analysis of mouse liver homogenates.